![Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo® Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo®](https://mma.prnewswire.com/media/1557615/Logos_Distribucion_M8.jpg?p=twitter)
Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo®
![Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2 - Journal of Hospital Infection Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2 - Journal of Hospital Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/69a36d00-cae3-40be-872f-269fbc183712/gr1_lrg.jpg)
Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2 - Journal of Hospital Infection
![The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - ScienceDirect The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213398421001342-gr1.jpg)
The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - ScienceDirect
![The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - ScienceDirect The antiviral activity of iota-, kappa-, and lambda-carrageenan against COVID-19: A critical review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213398421001342-gr2.jpg)